Home / Knowledge Centre /
Article

Spotlight on stability: API and drug product testing

Stability studies are key to drug development. An integral part of any New Drug Application (NDA) is to perform stability studies on active pharmaceutical ingredients (APIs) and drug products to assess degradation and inform shelf-life prior to market release. For some programmes, further investigation is required to demonstrate stability of key raw materials, intermediates or excipients used in the manufacturing process. Anna Cousens, Business Development Manager at Almac Sciences, describes what studies need to be performed, and how, to ensure best product performance.

View Resource
Spotlight on stability: API and drug product testing

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies